ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
February 02 2010 - 7:00AM
PR Newswire (US)
SAN DIEGO, Feb. 2 /PRNewswire-FirstCall/ -- ADVENTRX
Pharmaceuticals, Inc. (NYSE Amex: ANX) today announced that the
Company's Principal Executive Officer, Brian M. Culley, will
present at the 12th Annual BIO CEO & Investor Conference on
Tuesday, February 9, 2010, at 10:30 a.m. Eastern time, in the Park
South room at the Waldorf Astoria in New York. The conference is
being hosted by the Biotechnology Industry Association. Interested
parties can access a live audio webcast and slide presentation on
the ADVENTRX Pharmaceuticals Web site at http://www.adventrx.com/.
An archived presentation will be available on the Web site for 30
days. About ADVENTRX Pharmaceuticals ADVENTRX Pharmaceuticals is a
specialty pharmaceutical company whose product candidates are
designed to improve the performance of existing cancer treatments
by addressing limitations associated principally with their safety
and use. More information can be found on the Company's Web site at
http://www.adventrx.com/. DATASOURCE: ADVENTRX Pharmaceuticals,
Inc. CONTACT: Brian Culley, Principal Executive Officer of ADVENTRX
Pharmaceuticals, +1-858-552-0866; or Investors, Don Markley of
Lippert/Heilshorn & Associates, Inc., +1-310-691-7100, , for
ADVENTRX Pharmaceuticals Web Site: http://www.adventrx.com/
Copyright